-+ 0.00%
-+ 0.00%
-+ 0.00%

AstraZeneca, Tempus AI Extend Master Services Agreement

MT Newswires·11/18/2026 10:50:02
Listen to the news
10:50 AM EST, 11/18/2026 (MT Newswires) -- AstraZeneca (AZN.L, AZN.ST) and Tempus AI (F3M.F) agreed to extend their master services agreement by an additional five years, starting from Jan. 1, 2027, to Dec. 31, 2031. Under the fifth amendment to the agreement dated November 2021, the British drugmaker pledged $200 million in fees payable to the US healthcare technology company, according to a Wednesday filing. AstraZeneca also committed to a minimum of $32 million in fees in each calendar year during the renewal period. The contract may be extended until Dec. 31, 2032, if the pledged amount is not met at the end of the period. AstraZeneca is also obliged to pay any shortfall if it decides to terminate the deal earlier.